Skip to content
10-K

Annual Report

FluoroPharma Medical, Inc.

0001415889-16-005393

← back to feed
Filed
Mar 30, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · Mar 27, 2016 33.22M sh
Capex restated FY 2015 · Dec 31, 2014 $6.56K
Operating Cash Flow FY 2015 · Dec 31, 2014 −$3.32M
Current Liabilities FY 2015 · Dec 31, 2014 $5.62M
Current Assets FY 2015 · Dec 31, 2014 $450.92K
Total Assets FY 2015 · Dec 31, 2014 $820.19K
Eps Basic FY 2015 · Dec 31, 2014 −$0.16
Sga Expense FY 2015 · Dec 31, 2014 $3.42M
Rd Expense FY 2015 · Dec 31, 2014 $1.75M
Net Income FY 2015 · Dec 31, 2014 −$4.13M
Cash And Equivalents FY 2015 · Dec 31, 2013 $1.14M
Stockholders Equity FY 2015 · Dec 31, 2013 −$1.06M